Therefore, in patients with GHPA combined with GD, controlling GH/IGF-1 levels not only helps to avoid further worsening of hyperthyroidism due to GD but also helps to reduce the clinical activity of GO. This evidence concerns the gene IGF1 and hyperthyroidism.